The Prognostic Significance of Minimal Residual Disease Monitoring by Wt1 Gene Expression in Peripheral Blood Before and after Allogeneic Stem Cell Transplantation in AML Patients

被引：0
|
作者：
Valkova, Veronika [1 ]
Vydra, Jan [1 ]
Markova, Marketa [1 ]
Vitek, Antonin [1 ]
Cerovska, Ela [1 ]
Belickova, Monika [1 ]
Novakova, Ludmila [1 ]
Cemusova, Barbora [1 ]
Koubova, Mariana [1 ]
Cetkovsky, Petr [1 ]
机构：
[1] Inst Hematol & Blood Transfus, Prague, Czech Republic
来源：
BONE MARROW TRANSPLANTATION | 2020年 / 55卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P028
引用
下载
收藏
页码：203 / 203
页数：1
相关论文
共 50 条
  • [21] DETECTION OF MINIMAL RESIDUAL DISEASE OF ACUTE CHILDHOOD LEUKEMIA BY FOLLOWING WT1 GENE EXPRESSION IN THE PERIPHERAL BLOOD
    Magyarosy, Edina
    Raso, Erzsebet
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3392 - 3393
  • [22] Prognostic significance of minimal residual disease after hematopoietic stem cell transplantation
    Gruhn, B
    Häfer, R
    Voigt, A
    Wittig, S
    Fuchs, D
    Hermann, J
    Zintl, F
    BONE MARROW TRANSPLANTATION, 2002, 29 : S124 - S124
  • [23] LONGITUDINAL FOLLOW UP OF MINIMAL RESIDUAL DISEASE IN AML AFTER SCT WITH QUANTITATIVE EVALUATION OF WT1 GENE EXPRESSION
    Candoni, A.
    Simeone, E.
    Gallina, R.
    Toffoletti, E.
    D'Odorico, C.
    Zanini, F.
    Fanin, R.
    HAEMATOLOGICA, 2012, 97 : 402 - 402
  • [24] Prognostic significance and kinetics of minimal residual disease in chronic lymphocytic leukemia after allogeneic stem cell transplantation
    Valkova, V.
    Vitek, A.
    Markova, M.
    Schwarz, J.
    Chovanec, P.
    Vydra, J.
    Novakova, L.
    Cetkovsky, P.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S494 - S494
  • [25] Monitoring of Wilms' Tumor 1 Expression As Minimal Residual Disease in Patients with Acute Myeloid Leukemia to Predict Relapse before and after Allogeneic Stem Cell Transplantation
    Dulery, Remy
    Nibourel, Olivier
    Elsermans, Vincent
    Beauvais, David
    Simonnet, Arthur
    Gauthier, Jordan
    Coiteux, Valerie
    Magro, Leonardo
    Quesnel, Bruno
    Preudhomme, Claude
    Yakoub-Agha, Ibrahim
    BLOOD, 2014, 124 (21)
  • [26] WT1 Expression for Monitoring Minimal Residual Disease In Acute Lymphoblastic Leukemia Patients
    Shmunk, Irina
    Koneva, Elena
    Suslova, Tatyana
    Zakharova, Marina
    Korobitsina, Olga
    Korobkin, Alexander
    Burmistrova, Alexandra
    BLOOD, 2010, 116 (21) : 1326 - 1327
  • [27] Prognostic value of minimal residual disease before allogeneic hematopoietic stem cell transplantation in patients with acute leukemia
    Konova, Z., V
    Parovichnikova, E. N.
    Galtseva, I., V
    Drokov, M. Yu
    Davydova, Yu O.
    Kapranov, N. M.
    Vasilyeva, V. A.
    Kuzmina, L. A.
    Savchenko, V. G.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2021, 66 (04): : 539 - 555
  • [28] Expression of and CD8+T cell responses to Wilms' tumor gene 1 (WT1) in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation
    Casalegno-Garduno, R.
    Meier, C.
    Schmitt, A.
    Hilgendorf, I
    Rohde, S.
    Spitschak, A.
    Hirt, C.
    Linnebacher, M.
    Puetzer, B.
    Freund, M.
    Schmitt, M.
    ONKOLOGIE, 2012, 35 : 93 - 93
  • [29] QUANTIFICATION OF WT1 GENE EXPRESSION FOR MRD DETECTION AS PREDICTOR OF RELAPSE IN PATIENTS WITH AML AFTER ALLOGENEIC STEM CELL TRANSPLANTATION COMPARED TO FLOW CYTOMETRY AND CHIMERISM
    Kwon, M.
    Infante, M.
    Carretero, F.
    Anguita, J.
    Perez-Corral, A.
    Serrano, D.
    Gayoso, J.
    Diez Martin, J.
    Buno, I.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 437 - 438
  • [30] PROGNOSTIC IMPACT OF WT1 GENE EXPRESSION QUANTIFICATION DURING MINIMAL RESIDUAL DISEASE MONITORING OF ACUTE PROMYELOCYTIC LEUKEMIA
    Mitrovic, M.
    Tosic, N.
    Suvajdzic, N.
    Djunic, I.
    Vidovic, A.
    Virijevic, M.
    Colovic, N.
    Glumac, I.
    Kostic, T.
    Pavlovic, S.
    Elezovic, I.
    Tomin, D.
    HAEMATOLOGICA, 2015, 100 : 377 - 378
12345